Dominant negative GPR161 rare variants are risk factors of human spina bifida.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 11 06 2018
accepted: 20 09 2018
pubmed: 27 9 2018
medline: 5 6 2019
entrez: 27 9 2018
Statut: ppublish

Résumé

Spina bifida (SB) is a complex disorder of failed neural tube closure during the first month of human gestation, with a suspected etiology involving multiple gene and environmental interactions. GPR161 is a ciliary G-protein coupled receptor that regulates Sonic Hedgehog (Shh) signaling. Gpr161 null and hypomorphic mutations cause neural tube defects (NTDs) in mouse models. Herein we show that several genes involved in Shh and Wnt signaling were differentially expressed in the Gpr161 null embryos using RNA-seq analysis. To determine whether there exists an association between GPR161 and SB in humans, we performed direct Sanger sequencing on the GPR161 gene in a cohort of 384 SB patients and 190 healthy controls. We identified six rare variants of GPR161 in six SB cases, of which two of the variants were novel and did not exist in any databases. Both of these variants were predicted to be damaging by SIFT and/or PolyPhen analysis. The novel GPR161 rare variants mislocalized to the primary cilia, dysregulated Shh and Wnt signaling and inhibited cell proliferation in vitro. Our results demonstrate that GPR161 mutations cause NTDs via dysregulation of Shh and Wnt signaling in mice, and novel rare variants of GPR161 can be risk factors for SB in humans.

Identifiants

pubmed: 30256984
pii: 5106747
doi: 10.1093/hmg/ddy339
pmc: PMC6321953
doi:

Substances chimiques

GPR161 protein, human 0
GPR162 protein, mouse 0
Hedgehog Proteins 0
Receptors, G-Protein-Coupled 0
SHH protein, human 0
Wnt Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

200-208

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD083809
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM113023
Pays : United States
Organisme : ACL HHS
ID : U01DD001033
Pays : United States
Organisme : NICHD NIH HHS
ID : P01 HD067244
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD081216
Pays : United States

Références

Nat Genet. 2007 Nov;39(11):1350-60
pubmed: 17906624
Birth Defects Res A Clin Mol Teratol. 2007 Mar;79(3):187-210
pubmed: 17177317
Hum Mol Genet. 2009 May 15;18(10):1719-39
pubmed: 19223390
Cell Rep. 2018 Jan 30;22(5):1169-1184
pubmed: 29386106
Dev Biol. 2015 Jun 1;402(1):17-31
pubmed: 25753732
J Med Genet. 1973 Sep;10(3):209-34
pubmed: 4590246
Birth Defects Res A Clin Mol Teratol. 2010 Aug;88(8):633-52
pubmed: 20544799
J Clin Endocrinol Metab. 2015 Jan;100(1):E140-7
pubmed: 25322266
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4191-6
pubmed: 24599592
J Biol Chem. 2002 May 31;277(22):19889-96
pubmed: 11886853
Paediatr Perinat Epidemiol. 1991 Oct;5(4):423-7
pubmed: 1754501
Birth Defects Res A Clin Mol Teratol. 2013 Jun;97(6):409-15
pubmed: 23761049
Nat Cell Biol. 2009 Oct;11(10):1225-32
pubmed: 19767740
Birth Defects Res A Clin Mol Teratol. 2010 Aug;88(8):653-69
pubmed: 20740593
Cell. 2013 Jan 17;152(1-2):210-23
pubmed: 23332756
Int J Clin Exp Pathol. 2013 Nov 15;6(12):2968-74
pubmed: 24294386
Development. 2018 Jan 8;145(1):
pubmed: 29222391
Hum Mol Genet. 2011 Nov 15;20(22):4324-33
pubmed: 21840926
Development. 2002 May;129(10):2507-17
pubmed: 11973281
Annu Rev Neurosci. 2014;37:221-42
pubmed: 25032496
Am J Med Genet C Semin Med Genet. 2005 May 15;135C(1):88-94
pubmed: 15800877
Development. 2017 Feb 15;144(4):552-566
pubmed: 28196803
N Engl J Med. 1976 Feb 12;294(7):365-9
pubmed: 1107843
Nat Commun. 2017 Nov 2;8(1):1275
pubmed: 29097673
Methods Cell Biol. 2015;127:303-22
pubmed: 25837398
Hum Mol Genet. 2009 Oct 15;18(R2):R113-29
pubmed: 19808787
Development. 2008 Aug;135(15):2489-503
pubmed: 18621990
Dev Biol. 2005 Jun 1;282(1):1-13
pubmed: 15936325
Science. 2013 Mar 1;339(6123):1222002
pubmed: 23449594
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2088-93
pubmed: 18250320
Cell Cycle. 2007 Nov 1;6(21):2640-9
pubmed: 17912034
Annu Rev Genet. 2014;48:583-611
pubmed: 25292356
Nat Rev Genet. 2010 May;11(5):331-44
pubmed: 20395968
Birth Defects Res A Clin Mol Teratol. 2005 Sep;73(9):591-6
pubmed: 16080189
Biochem Soc Trans. 2004 Dec;32(Pt 6):1048-50
pubmed: 15506960
Br Med Bull. 1974 May;30(2):158-63
pubmed: 4619574
Sci Signal. 2015 Jun 02;8(379):ra55
pubmed: 26038600
Int J Clin Exp Med. 2013 Oct 25;6(10):960-6
pubmed: 24260604

Auteurs

Sung-Eun Kim (SE)

Department of Pediatrics, Dell Pediatric Research Institute, University of Texas at Austin Dell Medical School, Austin, TX, USA.

Yunping Lei (Y)

Department of Pediatrics, Dell Pediatric Research Institute, University of Texas at Austin Dell Medical School, Austin, TX, USA.
Departments of Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, TX, USA.

Sun-Hee Hwang (SH)

Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX, USA.

Bogdan J Wlodarczyk (BJ)

Department of Pediatrics, Dell Pediatric Research Institute, University of Texas at Austin Dell Medical School, Austin, TX, USA.
Departments of Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, TX, USA.

Saikat Mukhopadhyay (S)

Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX, USA.

Gary M Shaw (GM)

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

M Elizabeth Ross (ME)

Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.

Richard H Finnell (RH)

Department of Pediatrics, Dell Pediatric Research Institute, University of Texas at Austin Dell Medical School, Austin, TX, USA.
Departments of Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH